Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab

J Am Acad Dermatol. 2020 Mar;82(3):758-761. doi: 10.1016/j.jaad.2019.09.040. Epub 2019 Sep 24.

Affiliations

¹ Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
² Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan. Electronic address: mkamata-tky@umin.ac.jp.
³ Department of Dermatology, Fujita Health University, Toyoake, Japan.

PMID: 31560979
DOI: 10.1016/j.jaad.2019.09.040

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized / therapeutic use*
Dermatologic Agents / therapeutic use*
Female
Humans
Male
Middle Aged
Psoriasis / drug therapy*
Psoriasis / pathology
Remission Induction

Substances

Antibodies, Monoclonal, Humanized
Dermatologic Agents
ixekizumab